SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000722830-19-000020
Filing Date
2019-10-30
Accepted
2019-10-30 16:07:40
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q immu-930201910q.htm   iXBRL 10-Q 1609663
2 EXHIBIT 31.1 immu-09302019ex311.htm EX-31.1 8443
3 EXHIBIT 32.1 immu-09302019ex321.htm EX-32.1 6770
  Complete submission text file 0000722830-19-000020.txt   5855123

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT immu-20190930.xsd EX-101.SCH 38038
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT immu-20190930_cal.xml EX-101.CAL 74205
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT immu-20190930_def.xml EX-101.DEF 229601
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT immu-20190930_lab.xml EX-101.LAB 558360
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT immu-20190930_pre.xml EX-101.PRE 319850
9 EXTRACTED XBRL INSTANCE DOCUMENT immu-930201910q_htm.xml XML 776849
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 191180068
SIC: 2835 In Vitro & In Vivo Diagnostic Substances